top of page
GRG's Center For Experiential Learning
Search
Unlocking the Potential of EGFR Testing in NSCLC: A Personalized Approach to Cancer Care
Lung cancer is still a deadly opponent, taking many lives throughout the world. Non-small cell lung cancer (NSCLC), approximately...
2 min read
GRG Health Competitive Intelligence (CI) Perspectives and Opinions, October 2022
The development : In October 2022, Dostarlimab met its primary endpoint of Objective Response Rate (ORR) in a head-to-head trial against...
4 min read
bottom of page